Ireland· IE-PA-EU/1/17/1178/015
XELJANZ 1 mg/mL oral solution
A tofacitinib product containing tofacitinib, registered in Ireland by Pfizer Europe MA EEIG. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tofacitinib is registered in 2 of 19 countries.
Countries holding a registration under ATC L04AA29 (tofacitinib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Tofacitinib · ATC L04AA29
2 / 19 countries
- Ireland
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- TOFACITINIB
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Ireland (IE)
- ATC code
- L04AA29
- ATC class
- Tofacitinib
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1178/015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
512 interactions on record for tofacitinib.
Graded by severity as the source publishes them — 333 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tofacitinib · interactions on record
512 records
- 333 severe
- 171 moderate
- 8 minor
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tofacitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTOFACITINIBNovadoz Pharmaceuticals LLC
- CzechiaXELJANZPfizer Europe MA EEIG, Bruxelles
- SpainXELJANZ 1 MG/ML SOLUCION ORALPfizer Europe Ma Eeig
- FinlandXeljanzPfizer Europe MA EEIG
- IcelandXELJANZPfizer Europe MA EEIG*
- BelgiumXeljanz 1 mg/mlPfizer Europe MA
- NorwayXeljanzPfizer Europe MA EEIG (1)
- PolandXeljanzPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Tofacitinib Devatis, Tofacitinib Stada
- Bulgaria · Tофацитиниб Devatis
- Denmark · Tofacitinib Accord, Tofacitinib Newbury
- Spain · Tofacitinib Stada
- Finland · Tofacitinib Devatis, Tofacitinib Stada
- France · Tofacitinib Stada
- United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
- Croatia · Tofacitinib Accord, Tofacitinib Stada
- Iceland · Xeljanz
- Liechtenstein · Xeljanz
- Malta · Tofacitinib Stada
- Netherlands · Tofacitinib Devatis, Tofacitinib Stada
- Norway · Tofacitinib Accord, Tofacitinib Devatis
- Portugal · Tofacitinib Bluepharma
- Sweden · Tofacitinib Devatis, Tofacitinib Newbury
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4830192-602a-45db-80ff-182c580cd06e GET /v1/drugs/b4830192-602a-45db-80ff-182c580cd06e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AA29"
],
"strength": null,
"pa_number": "EU/1/17/1178/015",
"substances": [
"TOFACITINIB"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "18/08/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tofacitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.